Gene · 396
Papers1,898
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,898
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complex interactions of cellular players in chronic Graft-versus-Host Disease. | Front Immunol | 2023 | 37435079 | PubTator, text mining | PubMed |
| Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2/NFκB signaling. | Cell Death Dis | 2023 | 37391410 | PubTator, text mining | PubMed |
| High Rate of Mutations of Adhesion Molecules and Extracellular Matrix Glycoproteins in Patients with Adult-Onset Focal and Segmental Glomerulosclerosis. | Biomedicines | 2023 | 37371859 | PubTator, text mining | PubMed |
| Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis. | Cells | 2023 | 37371090 | PubTator, text mining | PubMed |
| Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model. | Mol Cell Proteomics | 2023 | 37348606 | PubTator, text mining | PubMed |
| RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. | J Clin Invest | 2023 | 37317963 | PubTator, text mining | PubMed |
| Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy. | Int J Mol Sci | 2023 | 37298699 | PubTator, text mining | PubMed |
| ERK3 and DGKζ interact to modulate cell motility in lung cancer cells. | Front Cell Dev Biol | 2023 | 37287450 | PubTator, text mining | PubMed |
| Molecular dynamics simulations reveal the inhibition mechanism of Cdc42 by RhoGDI1. | J Comput Aided Mol Des | 2023 | 37286854 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. | Front Pharmacol | 2023 | 37284313 | PubTator, text mining | PubMed |
| Identification of novel oncogenes in oral cancer among elderly nonsmokers. | Clin Exp Dent Res | 2023 | 37272305 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families. | J Cell Sci | 2023 | 37232246 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| Maternal pre-conceptional glyphosate exposure impacts the offspring hepatic and ovarian proteome. | Toxicol Sci | 2023 | 37208198 | PubTator, text mining | PubMed |
| ACKnowledging the role of the Activated-Cdc42 associated kinase (ACK) in regulating protein stability in cancer. | Small GTPases | 2023 | 37194323 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| Identification of MYH9 as a key regulator for synoviocyte migration and invasion through secretome profiling. | Ann Rheum Dis | 2023 | 37188496 | PubTator, text mining | PubMed |
| Oxidants and Cardiorenal Vascular Remodeling-Insights from Rare Genetic Tubulopathies: Bartter's and Gitelman's Syndromes. | Antioxidants (Basel) | 2023 | 37107186 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer. | Front Oncol | 2023 | 37091166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/396/papers?page=6